Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Chronic fatigue syndrome is associated with diminished intracellular perforin.

Maher KJ, Klimas NG, Fletcher MA.

Clin Exp Immunol. 2005 Dec;142(3):505-11.

2.

Immunological abnormalities in patients with chronic fatigue syndrome.

Tirelli U, Marotta G, Improta S, Pinto A.

Scand J Immunol. 1994 Dec;40(6):601-8.

PMID:
7997849
3.

Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.

Fletcher MA, Zeng XR, Maher K, Levis S, Hurwitz B, Antoni M, Broderick G, Klimas NG.

PLoS One. 2010 May 25;5(5):e10817. doi: 10.1371/journal.pone.0010817.

4.

A novel flow cytometric assay focusing on perforin release mechanisms of cytotoxic T lymphocytes.

Weren A, Bonnekoh B, Schraven B, Gollnick H, Ambach A.

J Immunol Methods. 2004 Jun;289(1-2):17-26.

PMID:
15251408
5.

Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis.

Brenu EW, van Driel ML, Staines DR, Ashton KJ, Hardcastle SL, Keane J, Tajouri L, Peterson D, Ramos SB, Marshall-Gradisnik SM.

J Transl Med. 2012 May 9;10:88. doi: 10.1186/1479-5876-10-88.

6.
7.

Cytotoxic activity of T- and NK-cell lymphoma cells is not dependent on a mature cytotoxic phenotype.

Boehrer S, Schui DK, Chow KU, Hoelzer D, Mitrou PS, Weidmann E.

Leuk Lymphoma. 2002 Dec;43(12):2363-8.

PMID:
12613525
8.

Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome.

Curriu M, Carrillo J, Massanella M, Rigau J, Alegre J, Puig J, Garcia-Quintana AM, Castro-Marrero J, Negredo E, Clotet B, Cabrera C, Blanco J.

J Transl Med. 2013 Mar 20;11:68. doi: 10.1186/1479-5876-11-68.

9.

Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.

Huth TK, Brenu EW, Ramos S, Nguyen T, Broadley S, Staines D, Marshall-Gradisnik S.

Scand J Immunol. 2016 Jan;83(1):44-51. doi: 10.1111/sji.12388.

10.

Analysis of perforin expression in human peripheral blood lymphocytes, CD56+ natural killer cell subsets and its induction by interleukin-2.

Konjevic G, Schlesinger B, Cheng L, Olsen KJ, Podack ER, Spuzic I.

Immunol Invest. 1995 Mar;24(3):499-507.

PMID:
7540593
11.

Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome.

Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A.

J Pediatr. 2003 Mar;142(3):292-6.

PMID:
12640378
12.
13.

Cytolytic effector function is present in resting peripheral T lymphocytes.

Geisberg M, Dupont B.

Int Immunol. 1992 Nov;4(11):1273-81.

PMID:
1472478
14.

Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, Klimas NG, Marshall-Gradisnik SM.

J Transl Med. 2011 May 28;9:81. doi: 10.1186/1479-5876-9-81.

15.

Quantitative fluorescence measures for determination of intracellular perforin content.

Maher KJ, Klimas NG, Hurwitz B, Schiff R, Fletcher MA.

Clin Diagn Lab Immunol. 2002 Nov;9(6):1248-52.

16.

Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production.

Chiang SC, Theorell J, Entesarian M, Meeths M, Mastafa M, Al-Herz W, Frisk P, Gilmour KC, Ifversen M, Langenskiöld C, Machaczka M, Naqvi A, Payne J, Perez-Martinez A, Sabel M, Unal E, Unal S, Winiarski J, Nordenskjöld M, Ljunggren HG, Henter JI, Bryceson YT.

Blood. 2013 Feb 21;121(8):1345-56. doi: 10.1182/blood-2012-07-442558. Epub 2013 Jan 2.

17.

Localization of Fas ligand in cytoplasmic granules of CD8+ cytotoxic T lymphocytes and natural killer cells: participation of Fas ligand in granule exocytosis model of cytotoxicity.

Kojima Y, Kawasaki-Koyanagi A, Sueyoshi N, Kanai A, Yagita H, Okumura K.

Biochem Biophys Res Commun. 2002 Aug 16;296(2):328-36.

PMID:
12163021
18.

Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).

Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Wong N, Ramos S, Staines D, Marshall-Gradisnik S.

BMC Immunol. 2015 Jun 2;16:35. doi: 10.1186/s12865-015-0101-4.

19.

Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity.

Hazeldine J, Hampson P, Lord JM.

Aging Cell. 2012 Oct;11(5):751-9. doi: 10.1111/j.1474-9726.2012.00839.x. Epub 2012 Jun 19.

20.

The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.

Guillot B, Portalès P, Thanh AD, Merlet S, Dereure O, Clot J, Corbeau P.

Br J Dermatol. 2005 Apr;152(4):690-6.

PMID:
15840100

Supplemental Content

Support Center